Anna Trask - 02 Dec 2021 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
CHIEF PEOPLE, COMMUNITY & CULTURE OFFICER
Signature
/s/ Anna Trask
Issuer symbol
N/A
Transactions as of
02 Dec 2021
Net transactions value
-$33,688
Form type
4
Filing time
06 Dec 2021, 15:20:46 UTC
Previous filing
04 Nov 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBTX Common Stock Sale $31,293 -4,913 -65% $6.37 2,620 02 Dec 2021 Direct F1, F2
transaction DBTX Common Stock Sale $2,395 -378 -14% $6.34 2,242 02 Dec 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.615, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnotes (2) and (3) of this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.18 to $6.47, inclusive.

Remarks:

CHIEF PEOPLE, COMMUNITY & CULTURE OFFICER